News25/Ratings12
News · 26 weeks76-43%
2026-03-012026-08-23
Mix3190d
- Insider14(45%)
- Other8(26%)
- SEC Filings6(19%)
- Earnings1(3%)
- Leadership1(3%)
- Analyst1(3%)
Latest news
25 items- PRMiniMed to Participate in Upcoming Investor ConferencesNORTHRIDGE, Calif., Aug. 25, 2026 /CNW/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced that management will participate in fireside chats at the following investor conferences: 21st Annual Wells Fargo Healthcare ConferenceTuesday, September 8, 2026, at 3:00 p.m. EDT / 12:00 p.m. PDTManagement: Que Dallara, Chief Executive OfficerBank of America Global Healthcare Conference 2026Wednesday, September 23, 2026, at 10:55 a.m. BST / 5:55 a.m. EDT / 2:55 a.m. PDTManagement: Que Dallara, Chief Executive Officer, and Chad Spooner, EVP, Chief Financial OfficerLive webcasts and replays will be accessible
- SECSEC Form DEFA14A filed by MiniMed Group Inc.DEFA14A - MiniMed Group, Inc. (0002062583) (Filer)
- SECSEC Form DEF 14A filed by MiniMed Group Inc.DEF 14A - MiniMed Group, Inc. (0002062583) (Filer)
- PRMiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest SensorMiniMed Flex™ with Instinct, made by Abbott, combines discreet design, up to 15 days of sensor wear and proven automation to reduce the work and interruptions of diabetes management NORTHRIDGE, Calif., Aug. 17, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED) today announced that the MiniMed Flex™ system is now commercially shipping in the U.S. with the Instinct sensor, made by Abbott. For the first time, people with diabetes can use MiniMed's smallest and only app-controlled insulin pump with the world's smallest sensor, with up to 15 days of wear.1 Diabetes technology has advanced significantly, but it can still place a heavy burde
- SECMiniMed Group Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - MiniMed Group, Inc. (0002062583) (Filer)
- INSIDERSVP, Gen. Counsel, Corp. Sec. Wills Courtney Nelson covered exercise/tax liability with 1,762 shares, decreasing direct ownership by 1% to 136,384 units (SEC Form 4) (withholding tax)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDEREVP Ch. Prod. & Tech Officer Dianaty Ali covered exercise/tax liability with 8,012 shares, decreasing direct ownership by 2% to 315,158 units (SEC Form 4) (withholding tax)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERChief Executive Officer Dallara Que covered exercise/tax liability with 31,350 shares, decreasing direct ownership by 3% to 884,749 units (SEC Form 4) (for tax liability)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDEREVP, Chief Financial Officer Spooner Chad covered exercise/tax liability with 23,301 shares, decreasing direct ownership by 6% to 362,707 units (SEC Form 4) (withholding obligation)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSVP, Chief HR Officer Chandrasena Gillian covered exercise/tax liability with 2,099 shares, decreasing direct ownership by 1% to 172,745 units (SEC Form 4) to cover withholding tax4 - MiniMed Group, Inc. (0002062583) (Issuer)
- ANALYSTUBS initiated coverage on MiniMed with a new price targetUBS initiated coverage of MiniMed with a rating of Buy and set a new price target of $25.00
- PRMiniMed Flex™ Now Available to Medicare and Medicare Advantage BeneficiariesNORTHRIDGE, Calif., July 22, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced that Medicare and Medicare Advantage beneficiaries now have access to the MiniMed Flex™ system with its latest sensor portfolio. This milestone now makes the company's smallest and only app-controlled insulin pump system available to more people living with diabetes. Designed to fit more naturally into everyday life, MiniMed Flex™ helps reduce the daily burden of diabetes management so people can focus more on the moments that matter to them. MiniMed Flex™ is about half the size* of previous MiniMed p
- PRMiniMed to Announce Its Fiscal Year 2027 First Quarter Financial ResultsNORTHRIDGE, Calif., July 20, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced that it expects to report financial results on Tuesday, September 1, 2026, for its first quarter of fiscal year 2027, which ends on Friday, July 31, 2026. A news release containing summary financial information is expected at approximately 3:45 a.m. Pacific Daylight Time (PDT) and will be available at https://news.minimed.com.A webcast discussing results is expected be held from 5:45 to 6:30 a.m. PDT, accessible at https://investors.minimed.com.A replay of the webcast and transcript of the prepared re
- INSIDERSEC Form 3 filed by new insider Endicott David J.3 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSEC Form 3 filed by new insider Burman Linnea3 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSVP, Gen. Counsel, Corp. Sec. Wills Courtney Nelson was granted 82,787 shares, increasing direct ownership by 150% to 138,146 units (SEC Form 4)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERVP, Chief Accounting Officer Gyurci John was granted 24,244 shares, increasing direct ownership by 154% to 39,941 units (SEC Form 4)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSVP, Chief HR Officer Chandrasena Gillian was granted 44,188 shares, increasing direct ownership by 34% to 174,844 units (SEC Form 4)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDEREVP, Chief Financial Officer Spooner Chad was granted 116,607 shares, increasing direct ownership by 43% to 386,008 units (SEC Form 4)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDEROfficer Dianaty Ali was granted 131,312 shares, increasing direct ownership by 68% to 323,170 units (SEC Form 4)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERChief Executive Officer Dallara Que was granted 297,618 shares, increasing direct ownership by 48% to 916,099 units (SEC Form 4)4 - MiniMed Group, Inc. (0002062583) (Issuer)
- INSIDERSEC Form 3 filed by new insider Cundy Scott T3 - MiniMed Group, Inc. (0002062583) (Issuer)
- SECSEC Form 10-K filed by MiniMed Group Inc.10-K - MiniMed Group, Inc. (0002062583) (Filer)
- SECMiniMed Group Inc. filed SEC Form 8-K: Leadership Update, Shareholder Director Nominations, Other Events, Financial Statements and Exhibits8-K - MiniMed Group, Inc. (0002062583) (Filer)
- PRMiniMed appoints Alcon CEO David Endicott and Linnea Burman to its Board of DirectorsDavid Endicott, Chief Executive Officer of Alcon, brings global healthcare leadership and public company experience; Linnea Burman adds MedTech operating depthNORTHRIDGE, Calif., June 29, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced that David Endicott and Linnea Burman have joined its Board of Directors, effective today, expanding the Board from nine to 11 members. Endicott will serve as a member of the Board's Compensation and Talent Committee. David Endicott, Chief Executive Officer of Alcon, brings global healthcare leadership and public company experienceAs MiniMed bui
MMED FAQ
6 questionsWhere does MMED stock trade?
MiniMed Group Inc. (MMED) is listed on NASDAQ.What sector and industry is MMED in?
MiniMed Group Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did MiniMed Group Inc. go public?
MiniMed Group Inc. (MMED) completed its IPO in 2026.What are analysts saying about MMED?
MiniMed Group Inc. has had 8 recent analyst actions on file. The most recent action was from UBS: Buy with a $2500.00 price target on 2026-07-28. Recent price targets range from $1600.00 to $2700.00.What companies are similar to MMED?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare MMED side-by-side with any of them on Quantisnow.How can I track MMED on Quantisnow?
Quantisnow aggregates MiniMed Group Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MMED to receive live email and push alerts on every new disclosure.